nile blue has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Li, L; Lu, W; Mao, Y; Song, Q; Sun, Y | 1 |
| Chang, N; Chen, R; Dong, J; Ge, Q; Liu, B; Luan, C; Ni, H; Zhao, X | 1 |
2 other study(ies) available for nile blue and Cancer of Prostate
| Article | Year |
|---|---|
A SERS-LFA biosensor combined with aptamer recognition for simultaneous detection of thrombin and PDGF-BB in prostate cancer plasma.
Topics: Aged; Antibodies, Monoclonal; Aptamers, Nucleotide; Becaplermin; Biosensing Techniques; Blood Chemical Analysis; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Middle Aged; Oxazines; Prostatic Neoplasms; Sensitivity and Specificity; Silver; Spectrum Analysis, Raman; Thrombin | 2021 |
Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
Topics: alpha-Fetoproteins; Animals; Antibodies; Biomarkers, Tumor; Biosensing Techniques; Carcinoembryonic Antigen; Collodion; Coloring Agents; Goats; Gold; Humans; Immunoassay; Kallikreins; Limit of Detection; Male; Metal Nanoparticles; Oxazines; Porosity; Prostate-Specific Antigen; Prostatic Neoplasms; Silver; Spectrum Analysis, Raman; Sulfhydryl Compounds | 2019 |